What is Proklean?
Founded in 2012, Proklean has established a robust market presence by replacing hazardous chemical agents with environmentally benign probiotic formulations. Operating under the brand name Proviera, the company provides high-efficiency solutions tailored for the leather processing, textile manufacturing, and hospitality sectors. Its core value proposition lies in the ability to reduce water consumption and chemical waste without compromising operational performance. By integrating biological innovation into industrial workflows, Proklean addresses the urgent need for ESG-compliant manufacturing, effectively bridging the gap between high-output industrial requirements and ecological stewardship.
How much funding has Proklean raised?
Proklean has raised a total of $4M across 1 funding round:
Other Financing Round
$4M
Other Financing Round (2023): $4M with participation from Raintree Family Office
Key Investors in Proklean
Raintree Family Office
Raintree Family Office is a dedicated investment firm focused on climate solutions, sustainability, and responsible consumption, managing capital pools that prioritize ESG-aligned and impact-driven enterprises.
What's next for Proklean?
With this recent capital injection, Proklean is well-positioned to scale its operations and expand its footprint in international markets. The company is expected to prioritize the enhancement of its R&D capabilities to further diversify its probiotic product portfolio. As global regulatory frameworks tighten around chemical usage in textiles and leather, Proklean's strategic focus will likely shift toward aggressive market penetration and the optimization of its supply chain to meet the needs of large-scale enterprise clients. This growth trajectory suggests a maturation phase where the company moves from early-stage innovation to becoming a standard-bearer for sustainable industrial chemistry.
See full Proklean company page
